Mechanisms of Modulation of Gut Immunity by Ingested Uranium and Mixed Metal Exposures

NIH RePORTER · NIH · P42 · $263,111 · view on reporter.nih.gov ↗

Abstract

BioProject- Gut (BP Gut) focuses on mechanisms of metal-induced immunotoxicity in the gastrointestinal tract (GIT) of mice and humans in a series of studies using mouse and human cells and tissues. BP Gut is highly integrated with all SRP METALS environmental and biologic projects, including BP Lung and BP Comm. BP Gut relies on the work of the CEC and the DMAC. An overall theme of the studies is the understanding of how metals present in or near mine sites in New Mexico might expose community members leading to immunotoxicity. We focus on soluble and particulate forms uranium (U), and vanadium (V) given via oral routes of exposure, because multiple exposures to these types of mixed metals has been observed in our community partners. We have previously shown during Phase 1 that oral (45d) drinking water exposure of mice to U leads to high exposures of GIT leading to significant changes in lymphoid and epithelial cells in the small and large intestines. In SA1, mouse studies will explore in vivo, ex vivo, and in vitro studies following exposures to uranyl acetate (UA, soluble) and uranium citrate (UCit, insoluble nanomaterial), sodium orthovanadate (Na3VO4, soluble) and vanadium oxide (V2O4, insoluble). These metals will be explored alone and in combination with other metals, including arsenic. Environmentally derived mine samples rich in carnotite will also be studied in mice. We will screen for mRNA changes in small and large intestinal snips focusing on cytokines, oxidative stress, and aromatic hydrocarbon receptor (AhR) pathways. An additional novel aspect of these studies is that we will perform microbiome metagenomic analyses on the feces obtained from these mice, and we will screen the feces using a large metabolomic panel to determine possible pathways responsible for immune modulation. In SA2, we will examine the toxicity of these same metals and mixtures on human colonic organoids obtained from normal human donors. We will assess metabolic changes in these tissues following in vitro exposures and we will assess changes in epithelial barrier function using both organoids and human colonic cell lines. Changes in transepithelial electrical resistances, mRNA and protein expression for membrane tight junction molecules will be studied to understand mechanisms of barrier disruption. In SA3, working with the CEC and BP Comm, we will examine stool samples from study participants in the community for metal exposure, changes in inflammatory biomarkers, microbiome metagenomics, and metabolomic profiles examined in SA1 and SA2. These studies will rely on statistical and mixed metal analyses developed by DMAC. The ultimate goal of these studies is to address community concerns regarding exposure to mixed metals from abandoned uranium mines and other hard metal mines leading to potential immunologic changes and diseases. Data from these studies will inform communities through CEC on how to avoid exposures and inform environmental projects (ESE PM, ESE...

Key facts

NIH application ID
10890052
Project number
5P42ES025589-08
Recipient
UNIVERSITY OF NEW MEXICO HEALTH SCIS CTR
Principal Investigator
Eliseo F Castillo
Activity code
P42
Funding institute
NIH
Fiscal year
2024
Award amount
$263,111
Award type
5
Project period
2017-08-15 → 2025-06-30